Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shun Lu

Showing results (371-380 of 706) with videos related to

Pageof 71
Sort By:
Future Oncology (London, England)|April 24, 2025
Plain language summary of first-line amivantamab-lazertinib in previously untreated high-risk EGFR-altered non-small-cell lung cancer in MARIPOSAEnriqueta Felip, Byoung Chul Cho, Shun Lu, et al.
Chemotherapy|November 25, 2010
A cost-effectiveness analysis of docetaxel versus pemetrexed in second-line chemotherapy for stage IIIb or IV non-small cell lung cancer in ChinaYong-feng Yu, Zhi-wei Chen, Zhen Zhou, et al.
Zhonghua Yi Xue Za Zhi|October 10, 2007
[Incidence, time trend, survival, and predictive factors of lung cancer in Shanghai populations]Mei-lin Liao, Zhi-wei Chen, Ying Zheng, et al.
Cancer Medicine|October 15, 2020
Clinical characteristics and survival outcomes of ascending, descending and mixed types of nasopharyngeal carcinoma in the non-endemic areas of china: A propensity score matching analysisYixin Fan, Wenqiang Guan, Rui Huang, et al.
Clinical Lung Cancer|June 15, 2024
Updated Efficacy and Safety of Lorlatinib in a Phase 2 Study in Chinese Patients With Previously Treated Advanced ALK-Positive Non-small Cell Lung CancerShun Lu, Qing Zhou, Xiaoqing Liu, et al.
Future Oncology (London, England)|December 3, 2024
Plain language summary: updated results of lorlatinib treatment in people with advanced NSCLC from ChinaShun Lu, Qing Zhou, Xiaoqing Liu, et al.
Frontiers in Oncology|September 29, 2025
Exploring the prognostic value of EBV DNA in advanced nasopharyngeal carcinoma treated with chemoradiotherapy using AI-based modelingYang Yang, Ningchuan Shang, Shun Lu, et al.
Medicine|September 9, 2020
Bilateral posterior fracture-dislocation of the shoulders: Two rare case reports and literature reviewJunwei Wu, Lianxin Li, Fengrui Wang, et al.
Journal for Immunotherapy of Cancer|May 9, 2025
BCL-2 mutant B7H6-CAR-T cells synergized with venetoclax for treating small cell lung cancerHuihui Zhang, Liliang Xia, Wendi Xuzhang, et al.
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi = Zhongguo Xiufu Chongjian Waike Zazhi = Chinese Journal of Reparative and Reconstructive Surgery|March 18, 2025
[Finite element analysis of impact of bone mass and volume in low-density zone beneath tibial plateau on cartilage and meniscus in knee joint]Longfei Han, Wenyuan Hou, Shun Lu, et al.
Pageof 71

Showing results (371-380 of 706) with videos related to

Sort By:
Pageof 71
Future Oncology (London, England)|April 24, 2025
Plain language summary of first-line amivantamab-lazertinib in previously untreated high-risk EGFR-altered non-small-cell lung cancer in MARIPOSAEnriqueta Felip, Byoung Chul Cho, Shun Lu, et al.
Chemotherapy|November 25, 2010
A cost-effectiveness analysis of docetaxel versus pemetrexed in second-line chemotherapy for stage IIIb or IV non-small cell lung cancer in ChinaYong-feng Yu, Zhi-wei Chen, Zhen Zhou, et al.
Zhonghua Yi Xue Za Zhi|October 10, 2007
[Incidence, time trend, survival, and predictive factors of lung cancer in Shanghai populations]Mei-lin Liao, Zhi-wei Chen, Ying Zheng, et al.
Cancer Medicine|October 15, 2020
Clinical characteristics and survival outcomes of ascending, descending and mixed types of nasopharyngeal carcinoma in the non-endemic areas of china: A propensity score matching analysisYixin Fan, Wenqiang Guan, Rui Huang, et al.
Clinical Lung Cancer|June 15, 2024
Updated Efficacy and Safety of Lorlatinib in a Phase 2 Study in Chinese Patients With Previously Treated Advanced ALK-Positive Non-small Cell Lung CancerShun Lu, Qing Zhou, Xiaoqing Liu, et al.
Future Oncology (London, England)|December 3, 2024
Plain language summary: updated results of lorlatinib treatment in people with advanced NSCLC from ChinaShun Lu, Qing Zhou, Xiaoqing Liu, et al.
Frontiers in Oncology|September 29, 2025
Exploring the prognostic value of EBV DNA in advanced nasopharyngeal carcinoma treated with chemoradiotherapy using AI-based modelingYang Yang, Ningchuan Shang, Shun Lu, et al.
Medicine|September 9, 2020
Bilateral posterior fracture-dislocation of the shoulders: Two rare case reports and literature reviewJunwei Wu, Lianxin Li, Fengrui Wang, et al.
Journal for Immunotherapy of Cancer|May 9, 2025
BCL-2 mutant B7H6-CAR-T cells synergized with venetoclax for treating small cell lung cancerHuihui Zhang, Liliang Xia, Wendi Xuzhang, et al.
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi = Zhongguo Xiufu Chongjian Waike Zazhi = Chinese Journal of Reparative and Reconstructive Surgery|March 18, 2025
[Finite element analysis of impact of bone mass and volume in low-density zone beneath tibial plateau on cartilage and meniscus in knee joint]Longfei Han, Wenyuan Hou, Shun Lu, et al.
Pageof 71